AstraZeneca UK Ltd. - Resultados de la búsqueda

Unión Europea - español - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Unión Europea - español - EMA (European Medicines Agency)

tezspire

astrazeneca ab - tezepelumab - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.

Unión Europea - español - EMA (European Medicines Agency)

imjudo

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - agentes antineoplásicos - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

crestor 10 mg comprimidos recubiertos con pelicula

astrazeneca ab - rosuvastatina calcica - excipientes: lactosa monohidrato,lactosa monohidrato,triacetina - agentes modificadores de los lÍpidos, monofÁrmacos - inhibidores de la hmg coa reductasa - rosuvastatina